Feline hyperthyroidism is the most common endocrine disease in older cats — long-term management choices significantly affect quality of life outcomes.
Long-term quality of life for hyperthyroid cats depends heavily on treatment choice and follow-up monitoring. While radioactive iodine offers the best long-term welfare outcome through cure, access and cost are barriers. Oral methimazole can achieve excellent control when cats tolerate it, but twice-daily pilling causes stress for many cats — owner training in low-stress pilling techniques and use of transdermal gel formulations improves compliance. The CKD unmasking phenomenon requires staged management: pre-treatment renal assessment and careful post-treatment monitoring prevents iatrogenic harm. Cats achieving stable thyroid hormone control regain body weight, recover cardiac health, and demonstrate improved behavioral indicators of quality of life including renewed grooming and social engagement.